OICR News / Tag

John Bartlett

Browse news tagged John Bartlett.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

TechnologyDiagnosis

Sometimes the simpler, the better: bringing personalized treatment selection for bladder cancer closer to the clinic

Pathology experts review challenges and opportunities in treatment selection for muscle-invasive bladder cancer (MIBC), propose traditional pathology method to achieve same results as molecular profiling at lower cost Research has shown that some types of…

ArticleFeb 12, 2019

TechnologyBreast cancer

Researchers investigated almost 200,000 cases of breast cancer: Here’s what they found

Research team finds aggressive breast cancers are less frequent than previously thought, and less aggressive breast cancers need more of our attention. Different subtypes of breast cancer respond to treatment differently and require different…

ArticleOct 24, 2018

TechnologyBreast cancer

Breaking down barriers to translation: A case of standardization in digital pathology

OICR takes part in international multicentre study to standardize promising breast cancer digital pathology test The Ki67 immunohistochemistry assay is a test that can help evaluate the aggressiveness of breast tumours, predict disease outcomes, monitor…

ArticleSep 24, 2018

TechnologyBreast cancer

New guidelines for HER2 testing in breast cancer

Current HER2 tests help predict which breast cancer patients will respond to HER2-targeted therapies, but sometimes these tests provide unclear results. An Expert Panel of pathologists and cancer researchers, including Dr. John Bartlett from OICR,…

ArticleJun 04, 2018

Collaboration

The Canadian Data Integration Centre receives new funding to help cancer researchers translate findings to patients

Toronto (January 25, 2018) – The Canadian Data Integration Centre (CDIC) has received $6.4 million in funding from Genome Canada to help the research community translate the biological insights gained from genomics research into tangible…

ArticleJan 25, 2018

TechnologyBreast cancer

Large-scale study provides clearer picture of recurrence risk for ER-positive breast cancer

Endocrine therapy uses hormone antagonists to greatly reduce the risk of disease recurrence in women with early-stage, estrogen-receptor (ER) positive breast cancer. However, the treatment can come with severe side effects. Around 30 per cent…

ArticleJan 12, 2018

← Previous Next stories →

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

John Bartlett

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Sometimes the simpler, the better: bringing personalized treatment selection for bladder cancer closer to the clinic ﻿

Researchers investigated almost 200,000 cases of breast cancer: Here’s what they found

Breaking down barriers to translation: A case of standardization in digital pathology

New guidelines for HER2 testing in breast cancer

The Canadian Data Integration Centre receives new funding to help cancer researchers translate findings to patients

Large-scale study provides clearer picture of recurrence risk for ER-positive breast cancer

Sometimes the simpler, the better: bringing personalized treatment selection for bladder cancer closer to the clinic